**Who this is for** This position is for an analytical leader with extensive experience in pharmaceutical forecasting who wants to shape the commercial strategy
Work type: hybrid
Location: Redwood City, California, United States
Salary: $211,000 – $264,000/yr
Type: Full-time
**Who this is for** This position is for an analytical leader with extensive experience in pharmaceutical forecasting who wants to shape the commercial strategy for lung oncology assets. **Key highlights** You will build and manage patient-based models and demand forecasts, partnering with cross-functional teams to translate complex data into actionable insights for manufacturing and commercial decision-making. **You might be a good fit if you...** - Have 8+ years of experience in biotech or pharmaceutical forecasting, including the use of secondary data like IQVIA. - Are proficient in developing patient-based modeling, sensitivity analysis, and scenario planning. - Hold a degree in a quantitative field such as statistics, economics, or life sciences. - Can effectively communicate complex model assumptions and risks to senior executive stakeholders.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
Reporting to the Senior Director, U.S. Forecasting, the Director, U.S. Forecasting will be responsible for developing and executing forecasting models and analyses that support product strategy, performance management, and operational planning.
This role focuses on building and maintaining short-term demand forecasts and patient-based models across U.S. oncology assets, enabling manufacturing, supply chain, and commercial decision-making. The Director will partner closely with cross-functional stakeholders to align on forecast inputs, assumptions, and outputs, while ensuring high-quality, timely deliverables.
As a key contributor within the U.S. Forecasting function, this individual will execute forecasting processes in alignment with the broader U.S. forecasting strategy and contribute to ongoing improvements in forecasting capabilities, tools, and data integration.
This position is based at our Redwood City, CA headquarters, with flexibility for remote candidates willing to travel regularly to the office.
Responsibilities include:
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.